Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.


This video from IQVIA Institute Executive Director Murray Aitken offers a look back at highlights of Institute activities in 2024, including reports and other publications, webinars, and symposia.
Enabling agility through global diversification
Annual trend report from the IQVIA Institute for Human Data Science
Annual report on medicine spending trends in the U.S.
This report from the IQVIA Institute reflects on the current state of the end-to-end environment for cell and gene therapies
Annual trend report from the IQVIA Institute for Human Data Science
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.